Log in to search using one of your social media accounts:

Pitt study provides clues to relationship between Schizophrenia and Rheumatoid arthritis
(University of Pittsburgh Schools of the Health Sciences) Bioinformatics study identifies genetic variants with differing effects on risk of rheumatoid arthritis and schizophrenia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2017 Category: Global & Universal Source Type: news

New assay may lead to a cure for debilitating inflammatory joint disease
Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Known as autoantibodies and produced by the immune system's B cells, these defective molecules mistakenly attack the body's own proteins in an example of autoimmune disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 24, 2017 Category: Science Source Type: news

New assay may lead to a cure for debilitating inflammatory joint disease
(NYU Langone Medical Center / New York University School of Medicine) Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Known as autoantibodies and produced by the immune system's B cells, these defective molecules mistakenly attack the body's own proteins in an example of autoimmune disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 23, 2017 Category: Global & Universal Source Type: news

Baricitinib Might Offer Oral Alternative to Adalimumab in RA Baricitinib Might Offer Oral Alternative to Adalimumab in RA
A phase 3 trial in patients with rheumatoid arthritis who did not respond to methotrexate showed that the addition of baricitinib produced significant clinical improvements.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 22, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Drug used to treat arthritis could save stroke patients
British doctors are trialling the use of a rheumatoid arthritis drug which targets the inflammatory process in the brain caused by stroke in the same way it treats inflammation in an arthritic joint. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2017 Category: Consumer Health News Source Type: news

Diabetes or rheumatoid arthritis - conditions put YOU at greater risk of THIS disease
DIABETES is not the only condition which can increase the risk of developing heart disease. Rheumatoid arthritis sufferers are also at greater risk of of developing the potentially deadly condition. (Source: Daily Express - Health)
Source: Daily Express - Health - February 17, 2017 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis Guidance for Patients, by Patients Rheumatoid Arthritis Guidance for Patients, by Patients
Medscape speaks with Dr Jonathan Krant about a new resource for patients with rheumatoid arthritis, which was developed in part by patients.Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 17, 2017 Category: Consumer Health News Tags: Rheumatology Expert Interview Source Type: news

MI Risk 39% Lower for Patients With RA Taking TNF Inhibitors MI Risk 39% Lower for Patients With RA Taking TNF Inhibitors
Patients with rheumatoid arthritis who were treated with TNF inhibitors were less likely to develop myocardial infarction than those treated with conventional DMARDs.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Eli Lilly and Incyte receive EC ’s marketing authorisation approval for Olumiant
Eli Lilly and Incyte have secured marketing authorisation approval for Olumiant (baricitinib) 4mg and 2mg film-coated tablets from the European Commission (EC) to treat moderate-to-severe active rheumatoid arthritis (RA) in adult patients. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 15, 2017 Category: Pharmaceuticals Source Type: news

Self-reported childhood maltreatment and traumatic events among Israeli patients suffering from fibromyalgia and rheumatoid arthritis - Hellou R, H äuser W, Brenner I, Buskila D, Jacob G, Elkayam O, Aloush V, Ablin JN.
OBJECTIVE. The association between Fibromyalgia Syndrome (FMS) and childhood maltreatment and adversity has frequently been proposed but limited data exists regarding the transcultural nature of this association. METHODS. 75 Israeli FMS patients an... (Source: SafetyLit)
Source: SafetyLit - February 14, 2017 Category: Global & Universal Tags: Age: Adolescents Source Type: news

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis
Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU INDIANAPOLIS, Feb. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) and Incyte Corporation (INCY) announced today that the Eur... Biopharmaceuticals, Regulatory Eli Lilly, Incyte , Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 14, 2017 Category: Pharmaceuticals Source Type: news

Relationship expert teams up with Pfizer to address intimacy and relationship issues for people living with chronic diseases
Nationally-recognized relationship expert and author, Logan Levkoff, Ph.D., has partnered with Pfizer Inc. (NYSE:PFE) to fill a void in information available to people living with chronic diseases: relationship advice. Levkoff will address the topics of relationships and intimacy for those living with a chronic condition, like rheumatoid arthritis (RA), on the newly re-launched Arthritis.com site. (Source: World Pharma News)
Source: World Pharma News - February 10, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Rheumatoid Arthritis: Living With a Chronic Disease
Title: Rheumatoid Arthritis: Living With a Chronic DiseaseCategory: Doctor's& Expert's views on SymptomsCreated: 1/19/2012 12:00:00 AMLast Editorial Review: 2/9/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 9, 2017 Category: Rheumatology Source Type: news

Patient Story: Rheumatoid Arthritis Treatment
Title: Patient Story: Rheumatoid Arthritis TreatmentCategory: Doctor's& Expert's views on SymptomsCreated: 1/20/2012 12:00:00 AMLast Editorial Review: 2/9/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 9, 2017 Category: Rheumatology Source Type: news

Study of complex genetic region finds hidden role of NCF1 in multiple autoimmune diseases
(Medical University of South Carolina) Medical University of South Carolina investigators report pre-clinical research showing that a genetic variant encoded in neutrophil cystolic factor 1 (NCF1) is associated with increased risk for autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sj ö gren's syndrome, in the January 2017 issue of Nature Genetics. Data indicate that increased NCF1 protects against SLE while decreased NCF1 raises SLE risk and highlight the pathogenic role of reduced reactive oxygen species in autoimmune disease development. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 8, 2017 Category: Biology Source Type: news

Rheumatoid Arthritis Quiz: What is Rheumatoid Arthritis?
Title: Rheumatoid Arthritis Quiz: What is Rheumatoid Arthritis?Category: MedicineNet QuizCreated: 1/31/2011 12:00:00 AMLast Editorial Review: 2/6/2017 12:23:33 PM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 6, 2017 Category: Rheumatology Source Type: news

Medical News Today: Seronegative Rheumatoid Arthritis: Symptoms, Diagnosis, and Treatment
What is seronegative rheumatoid arthritis? What is rheumatoid factor? Learn about what tests may be used and if diet can help to manage symptoms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 3, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Health Canada approves Kevzara antibody to treat patients with rheumatoid arthritis
Sanofi has received approval from Health Canada for Kevzara (sarilumab), an interleukin-6 (IL-6) receptor antibody, to treat adult patients with moderately to severely active rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 2, 2017 Category: Pharmaceuticals Source Type: news

Drug combination effective against chikungunya arthritis in mice
Chikungunya virus causes a painful, debilitating arthritis for which there is currently no treatment. A new study has found that combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the earliest stage of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2017 Category: Science Source Type: news

Discovery of new T-cell subtype opens window on rheumatoid arthritis
Researchers have carefully scrutinized the immune cells from patients with rheumatoid arthritis, revealing a striking new subset of T-cells that collaborate with other immune cells to drive inflammation in peripheral tissues. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2017 Category: Science Source Type: news

Use of Biologic Therapy in Racial Minorities With RA Use of Biologic Therapy in Racial Minorities With RA
A new study investigates possible racial and ethnic disparities in the access and administration of biologic agents for rheumatoid arthritis. Are there discrepancies?Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Drug combination effective against chikungunya arthritis in mice
(Washington University School of Medicine) Chikungunya virus causes a painful, debilitating arthritis for which there is currently no treatment. A new study has found that combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the earliest stage of the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 1, 2017 Category: Infectious Diseases Source Type: news

Discovery of New T-Cell Subtype Opens Window on Rheumatoid Arthritis
Finding flows from researchers ’ use of high-tech tools to deeply and efficiently characterize patient cells (Source: BWH News)
Source: BWH News - February 1, 2017 Category: Hospital Management Source Type: news

Discovery of New T-Cell Subtype Opens Window on Rheumatoid Arthritis
Finding flows from researchers ’ use of high-tech tools to deeply and efficiently characterize patient cells (Source: BWH for Journalists)
Source: BWH for Journalists - February 1, 2017 Category: Research Source Type: news

Post-Test on Rheumatoid Arthritis in Primary Care
Use this short test to gauge how much you ’ve learned about a condition that needs more primary care involvement. (Source: ConsultantLive)
Source: ConsultantLive - January 30, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Quiz Special Report Source Type: news

Medical News Today: Natural Remedies for Rheumatoid Arthritis
Can a diet change and other lifestyle changes help reduce discomfort caused by rheumatoid arthritis? Learn about other natural remedies that may help. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 30, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Adalimumab Biosimilar Candidate Recommended for EMA Approval THOUSAND OAKS, Calif., Jan. 27, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 501 (biosimilar adalimumab), recommending approval for all available indications. ABP 501 has been recommended for approval for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis (AS)...
Source: Amgen News Release - January 27, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Immune cell study sheds new light on how inflammatory arthritis begins
This study, published in the medical journal Science Immunology, used multiphoton intravital microscopy - an imaging technology that allows immune cell movements to be tracked in real time - to follow the development of arthritis in lab mice withrheumatoid arthritis, in order to better understand how this works. It was revealed that the presence of immune complexes within the joint space leads to the production of a molecule called C5a, which is then displayed on the inner walls of adjacent blood vessels and causes immune cells called neutrophils to pass into the joint, setting off the process of inflammation. The implicat...
Source: Arthritis Research UK - January 25, 2017 Category: Rheumatology Source Type: news

Psoriatic Disease Tied to Elevated Fracture Risk Psoriatic Disease Tied to Elevated Fracture Risk
Patients with psoriatic arthritis and psoriasis may have the same increased risk for fracture as those with rheumatoid arthritis, according to a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Roche says FDA grants priority review for Actemra
ZURICH (Reuters) - The U.S. Food and Drug Administration (FDA) has granted priority review designation of Roche's rheumatoid arthritis medication Actemra for giant cell arteritis (GCA), the Swiss drugmaker said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - January 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Scripps Florida team awarded $1.8 million grant to develop drugs for heart disease and rheumatoid ar
(Scripps Research Institute) Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2017 Category: Global & Universal Source Type: news

Q & A: A Scientific Lens on Copper
Copper bracelets and other folk remedies, like magnetic straps, were no more effective against arthritis than a placebo, a study found. (Source: NYT Health)
Source: NYT Health - January 23, 2017 Category: Consumer Health News Authors: C. CLAIBORNE RAY Tags: Rheumatoid Arthritis Copper, Brass and Bronze Public Library of Science (PLoS) Source Type: news

8 New Rheumatoid Arthritis Findings
RA symptoms invisible but harmful, mortality increases with RA, plus 6 more highlights from recent RA studies of interest to primary care. (Source: ConsultantLive)
Source: ConsultantLive - January 22, 2017 Category: Internal Medicine Authors: Leo Robert Tags: Special Report Musculoskeletal Disorders Source Type: news

Empowering patients to be their own personal trainers to improve function and strength - Implementing NICE CG79
The programme demonstrates the implementation of NICE guideline CG79 for management of rheumatoid arthritis in adults. It specifically relates to the delivery of recommendations that patients should have access to specialist physiotherapy, with periodic review. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 20, 2017 Category: Consumer Health News Source Type: news

Biosimilars: Bringing Patients into the Conversation
There ’s no doubt that the cheaper cost of biosimilars versus their originator biologic, even though not as substantial as generics, make them very attractive to healthcare markets. But so far, biosimilar manufacturers have dedicated most of their efforts to convincing payers of thesecost benefits, seeing them as the primary gatekeeper of market access. However, by focusing just on payers, are they missing a trick? In the longer-term, manufacturers could benefit from educating and winning over a wider audience, and not justphysicians, but also patients.Cheaper prices should lead to greater access to biologic therapy,...
Source: EyeForPharma - January 20, 2017 Category: Pharmaceuticals Authors: Mariel Metcalfe Source Type: news

Rheumatoid Arthritis: 17 Warning Signs of Serious Complications
Title: Rheumatoid Arthritis: 17 Warning Signs of Serious ComplicationsCategory: Doctor's& Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications
Title: Rheumatoid Arthritis (RA): 17 Warning Signs of Serious ComplicationsCategory: Doctor's& Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

Living With Rheumatoid Arthritis
Title: Living With Rheumatoid ArthritisCategory: Doctor's& Expert's views on SymptomsCreated: 8/9/2006 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

MedImmune gets OK from China to pursue arthritis drug in joint venture deal
Gaithersburg-based MedImmune is expanding its footprint in China's drug market after receiving a permit to begin clinical trials there on a biologic therapy for rheumatoid arthritis. MedImmune, which is the R&D arm for London-based AstraZeneca (NYSE: AZN) drug giant AstraZeneca, produced the biologic in a joint venture with leading Chinese biologics manufacturer WuXi AppTech. This is the first collaboration of its kind between an multinational pharmaceutical corporation and a Chinese company, said… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 19, 2017 Category: American Health Authors: Tina Reed Source Type: news

Early Diagnosis of Rheumatoid Arthritis in Primary Care
Primary care physicians may contribute to improved outcomes by recognizing the signs and symptoms early on. Part 2 of a Special Report. (Source: ConsultantLive)
Source: ConsultantLive - January 17, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Special Report Musculoskeletal Disorders Source Type: news

Rheumatoid Arthritis
(RA) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 17, 2017 Category: Journals (General) Source Type: news

US FDA extends review period for Eli Lilly and Incyte ’s rheumatoid arthritis treatment
The US Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA) for Eli Lilly and Incyte ’s investigational baricitinib used to treat patients suffering from moderate-to-severe rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 16, 2017 Category: Pharmaceuticals Source Type: news

U.S. FDA Extends Review Period For Baricitinib, An Investigational Rheumatoid Arthritis Treatment
INDIANAPOLIS, Jan. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 13, 2017 Category: Drugs & Pharmacology Source Type: news

Rheumatoid Arthritis: Mortality Gap Narrows Rheumatoid Arthritis: Mortality Gap Narrows
Post-2000 treat-to-target regimens may underlie a drop in relative 5-year all-cause, cardiovascular, and cancer deaths among patients with early RA vs those in the general population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Ultrasound Imaging of Joints in Rheumatoid Arthritis (RA)
Title: Ultrasound Imaging of Joints in Rheumatoid Arthritis (RA)Category: Doctor's& Expert's views on SymptomsCreated: 2/6/2001 12:00:00 AMLast Editorial Review: 1/11/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 11, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis in Primary Care
This Special Report details the expanding role PCPs can play in serving an increasingly underserved population. (Source: ConsultantLive)
Source: ConsultantLive - January 9, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Special Report Musculoskeletal Disorders Source Type: news

Pfizer reports positive top-line data from REFLECTIONS B538-02 study of PF-06410293
Pfizer has reported positive top-line data from its REFLECTIONS B538-02 study of PF-06410293 compared with Humira to treat moderate-to-severe rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - January 9, 2017 Category: Pharmaceuticals Source Type: news

How BPA Exposure Lowers Vitamin D Levels
What do breast cancer, ADHD, diabetes, male fertility and autism have in common? They're very different conditions, but they've all been linked to a toxic group of chemicals called phthalates that we're all exposed to every day. Phthalates are in everything from food packaging to personal care products to dental fillings. In fact, they're so common in our environment that they're sometimes called "everywhere chemicals." And like so many of the toxins in our environment, phthalates throw your hormones out of whack. They cause estrogen levels to soar in both men and women. Ch...
Source: Al Sears, MD Natural Remedies - January 6, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Health Nutrition Source Type: news

Identifying Subtypes of Rheumatoid Arthritis Identifying Subtypes of Rheumatoid Arthritis
From the ACR meeting in Washington, DC, Dr Laura Donlin discusses her research exploring how subtyping rheumatoid arthritis could lead to more personalized treatment.Medscape Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 3, 2017 Category: Pathology Tags: Rheumatology Expert Interview Source Type: news